To review the number of Trabeculectomiescarried out at the Paci?c Eye Institute (PEI), the indi-cations for surgery, and explore this as a treatmentmodality that can be readily offered to patients in thePaci?c region.
Retrospective, interventional case series,including all trabeculectomies performed at the PEIfrom January 2012–December 2013. Outcome meas-ures used were best corrected visual acuity (BCVA),ntra-ocular pressure (IOP) and need for Glaucomamedications post-op.
There were 21 trabeculectomies done forthis period, 1 case was excluded due to unavailabi-lity of data. All patients had been on maximummedical therapy pre-operatively (in Fiji, this meansTimolol, Latanoprost, with systemic Acetazolomide asneeded), 15% had documented progression, and35% were blind in the other eye. 90% of patientsrecorded latest IOPs at or below 20 mmHg. Meanreduction in IOP was 59% at last recorded follow-up(Range 17–92%). Vision improved in 50% of eyes,worsened in 35%, and remained unchanged in15%. 80% of patients did not need Glaucoma dropspost-op.
There were generally good reductions inIOP and the majority of the patients did not need dropspost-operatively. This was a small audit and thefollow-up period is short, and not complete for somepatients. However, these preliminary results showpromise for Trabeculectomy as a valid Glaucoma treat-ment modality in the Paci?c region, particularly asGlaucoma medications are expensive, sporadic insupply and limited in range. Longer follow-up periodswill be necessary to see whether the reductions in IOPpersist over time.